SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 424B5
Document Type: 424B5
Date Filed: 2025-12-09
Accession Number: 0001213900-25-119671
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025119671/ea0268926-424b5_synergy.htm

Chunk 1 of 23
Word Count: 1436
Character Count: 9708

Document Content:

or to anyone to whom it is unlawful to make an offer or solicitation. You should assume that the information appearing in this prospectus supplement, the documents incorporated by reference into this prospectus, and in any free writing prospectus that we may authorize for use in connection with this offering, is accurate only as of the date of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the documents incorporated by reference into this prospectus supplement, and any free writing prospectus that we may authorize for use in connection with this offering, in their entirety before making an investment decision. You should also read and consider the information in the documents to which we have referred you in the sections of this prospectus supplement entitled “Where You Can Find More Information” and “Incorporation by Reference.”

We are offering to sell, and
seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The distribution of this prospectus
supplement and the offering of the common stock in certain jurisdictions may be restricted by law. Persons outside the United States who
come into possession of this prospectus supplement must inform themselves about, and observe any restrictions relating to, the offering
of the common stock and the distribution of this prospectus supplement outside the United States. This prospectus supplement does not
constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by
this prospectus supplement by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.

We further note that the representations,
warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into
the prospectus and accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant
to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of our affairs.

Unless otherwise stated, all
references to “us,” “our,” “Synergy,” “we,” the “Company” and similar designations
refer to Synergy CHC Corp. and its subsidiaries. Our logo, trademarks and service marks are the property of Synergy CHC Corp. and its
consolidated subsidiaries. Other trademarks or service marks appearing in this prospectus supplement are the property of their respective
holders.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus supplement
and the documents incorporated by reference herein contains forward-looking statements that reflect our current expectations and views
of future events. The forward-looking statements are contained principally in the sections included or incorporated by reference herein
entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Readers are cautioned that known and unknown risks, uncertainties and other factors, including those over which we may have no control
and others listed in the “Risk Factors” section of this prospectus supplement, may cause our actual results, performance or
achievements to be materially different from those expressed or implied by the forward-looking statements.

You can identify some of
these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,”
“aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,”
“potential,” “continue” or other similar expressions. We have based these forward-looking statements largely
on our current expectations and projections about future events that we believe may affect our financial condition, results of operations,
business strategy and financial needs. These forward-looking statements include statements relating to:

●	our ability to compete in our industry, including against competitors
that have significantly greater financial, technical and marketing resources than we do;

●	our ability to respond to customer preferences and successfully
develop new and innovative products in a timely manner and effectively manage the introduction of new or enhanced products;

●	risks related to a loss of, or material cancellation, reduction,
or delay in purchases by, one or more of our largest customers;

●	our outside suppliers and manufacturers failing to supply products
in sufficient quantities and in a timely fashion;

●	our ability to execute on our strategic initiatives (including
acquisitions);

●	our ability to maintain the reputation of our brands;

●	the risks related to consumers’ perception of the safety
and quality of our products as well as similar products distributed by other companies in our industry;

●	the risks related to third parties asserting intellectual property
infringement claims against us;

●	the risks related to our planned expansion into additional international
markets;

●	the risks related to adverse economic conditions;

●	the risks related to catastrophic events;

●	our ability to retain key personnel, manage our business effectively,
and continue to grow;

●	the impact of numerous laws and regulations that apply to the
manufacture, sale, and manufacturing of nutritional supplements, and compliance with these laws and regulations, as they currently exist
or as modified in the future, on us and our suppliers;

●	the risks related to product recalls; and

●	the risks related to product liability claims and litigation
to prosecute such claims.

These forward-looking statements
involve numerous risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are
reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that
we anticipate could be materially different from our expectations. Important risks and factors that could cause our actual results to
be materially different from our expectations are generally set forth in “Risk Factors,” “Management’s Discussion
and Analysis of Financial Condition and Results of Operations,” “Business,” “Regulation” and other sections
included or incorporated by reference in this prospectus supplement. You should thoroughly read this prospectus supplement and the documents
incorporated herein by reference with the understanding that our actual future results may be materially different from and worse than
what we expect. We qualify all of our forward-looking statements by these cautionary statements.

The forward-looking statements
made in this prospectus supplement relate only to events or information as of the date on which the statements are made in or incorporated
by reference in this prospectus supplement. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to
reflect the occurrence of unanticipated events. You should read this prospectus supplement, the documents incorporated by reference into
this prospectus supplement and the documents we have filed as exhibits to the registration statement, of which this prospectus supplement
forms a part, completely and with the understanding that our actual future results may be materially different from what we expect.

S-iii

PROSPECTUS SUPPLEMENT SUMMARY

This summary highlights
selected information contained elsewhere in this prospectus supplement. This summary does not contain all the information that you should
consider before investing in our Company. You should carefully read the entire prospectus supplement, including all documents incorporated
by reference herein. In particular, attention should be directed to our “Risk Factors,” “Information With Respect to
the Company,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the
financial statements and related notes thereto contained herein or otherwise incorporated by reference hereto, before making an investment
decision.

Our Company

We are a provider of consumer health care, beauty, and lifestyle products.
Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement (this study
was performed independently and is not related to any FDA-approved investigational new drug (IND) application) that has been shown
to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products
to help women achieve their nutrition and weight management goals. For the year ended December 31, 2024, FOCUSfactor represented
88% of our net revenue and Flat Tummy was 12%. For the nine months ended September 30, 2025, FOCUSfactor represented 86% of our net revenue
and Flat Tummy represented 14%. Our products are sold through some of the nation’s leading club, mass drug, and other retailers
such as Costco, Amazon.com, Walmart, Walgreens, CVS, BJ’s Wholesale Club, Publix Supermarkets, The Vitamin Shoppe, Target.com, H-E-B,
Meijer, and Albertson’s. Additionally, we have expanded into Canada and the United Kingdom.